Disease · MONDO_0005367
Trials19
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 1 more is not shown, since the checks do not confirm it.
1 to 19 of 19
Download this page as JSON| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00574067 | Buprenorphine for Prisoners | Phase 3 | 213 | 2016-04-11 | Heroin Addiction | BUPRENORPHINE | Its record names the disease | ClinicalTrials.gov |
| NCT00378079 | Methadone Maintenance for Prisoners | Phase 3 | 211 | 2014-04-03 | Heroin Addiction | METHADONE | Its record names the disease | ClinicalTrials.gov |
| NCT03711318 | Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals | Phase 3 | 8 | 2022-12-22 | Heroin Dependence | BUPRENORPHINE, NALOXONE | Its record names the disease | ClinicalTrials.gov |
| NCT01580163 | Efficacy Evaluation of Traditional Chinese Medicine JITAI Combined Comprehensive Model Among Heroin Addicts After Detoxification | Not applicable | 554 | Heroin Addiction | METHADONE | Its record names the disease | ClinicalTrials.gov | |
| NCT00142948 | Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts | Phase 2 | 301 | Heroin Dependence | GUANFACINE, NALTREXONE | Its record names the disease | ClinicalTrials.gov | |
| NCT01144390 | Effect Study of Optimized Intervention to Heroin Addicts | Not applicable | 240 | Heroin Dependence | METHADONE | Its record names the disease | ClinicalTrials.gov | |
| NCT00383045 | HIV Risk Reduction and Drug Abuse Treatment in Malaysia | Phase 2 | 180 | Opiate Dependence | BUPRENORPHINE, NALTREXONE | Its record names the disease | ClinicalTrials.gov | |
| NCT00292110 | Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management | Phase 1 | 140 | Opiate-Related Disorders, Cocaine-Related Disorders | METHADONE | Its record names the disease | ClinicalTrials.gov | |
| NCT00332228 | Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence | Phase 2 | 125 | Opiate Dependence | NALTREXONE | Its record names the disease | ClinicalTrials.gov | |
| NCT00726960 | Ability of Aprepitant to Block Opioid Reward in Non-Dependent Opiate Abusers | Phase 1 | 60 | Opioid-Related Disorders, Heroin Dependence, Substance-Related Disorders | APREPITANT | Its record names the disease | ClinicalTrials.gov | |
| NCT01174927 | Effects of Diacetylmorphine (DAM) on Brain Function and Stress Response | Phase 1 | 60 | Opiate | DIACETYLMORPHINE | Its record names the disease | ClinicalTrials.gov | |
| NCT01718964 | Acute Effects of Cortisol on Heroin Craving in Opioid Dependence (Ghost-Basel) | Phase 2 | 30 | Opioid Dependence | HYDROCORTISONE | Its record names the disease | ClinicalTrials.gov | |
| NCT00218309 | Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals | 16 | Heroin Dependence, Opioid-Related Disorders | HYDROMORPHONE | Its record names the disease | ClinicalTrials.gov | ||
| NCT00000273 | A Laboratory Model for Heroin Abuse Medications - 8 | Phase 2 | 8 | Heroin Dependence, Opioid-Related Disorders, Substance-Related Disorders | BUPRENORPHINE, FENTANYL, METHADONE, MORPHINE, NALTREXONE, OXYCODONE | Its record names the disease | ClinicalTrials.gov | |
| NCT02935101 | Effects of Glucocorticoids on Craving During Detoxification Treatment of Heroin and/or Stimulants | Phase 2 | 4 | Opioid Dependence, Cocaine Dependence | PREDNISOLONE | Its record names the disease | ClinicalTrials.gov | |
| NCT01723527 | Diversion to Treatment for Injection Drug Users Arrested for Possession of Heroin | Phase 1 | 1 | Cocaine-Related Disorders, HIV, Heroin Dependence | BUPRENORPHINE, METHADONE | Its record names the disease | ClinicalTrials.gov | |
| NCT00000210 | Treatment Efficacy for Drug Abuse and AIDS Prevention - 1 | Phase 2 | 0 | Cocaine-Related Disorders, Heroin Dependence | BUPRENORPHINE | Its record names the disease | ClinicalTrials.gov | |
| NCT00000211 | Treatment Efficacy for Drug Abuse and AIDS Prevention - 2 | Phase 2 | 0 | Cocaine-Related Disorders, Heroin Dependence | BUPRENORPHINE | Its record names the disease | ClinicalTrials.gov | |
| NCT00398008 | HIV Risk Reduction and Drug Abuse Treatment in Iran | Phase 2 | 0 | Opiate Dependence, HIV Infections | BUPRENORPHINE, NALTREXONE | Its record names the disease | ClinicalTrials.gov |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0005367/trials